Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients
Study of The Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients Using Tuberculin Skin Test at Sohag University Hospital
1 other identifier
observational
200
0 countries
N/A
Brief Summary
This observational cross-sectional study aims to determine the prevalence of latent tuberculosis infection (LTBI) among patients undergoing regular hemodialysis at Sohag University Hospital, using the tuberculin skin test (TST). Identifying the burden of LTBI in this high-risk population will help guide early detection and preventive strategies
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 7, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2027
October 7, 2025
September 1, 2025
1 year
September 30, 2025
September 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of latent tuberculosis infection among hemodialysis patients.
Percentage of patients with positive tuberculin skin test (defined as induration ≥10 mm).
Within 72 hours after TST administration.
Study Arms (1)
Hemodialysis Patients
Adult patients undergoing regular hemodialysis at Sohag University Hospital who will be screened for latent tuberculosis infection.
Interventions
Intradermal injection of 5 unit (0.1 mm) of purified protein derivative (PPD) with measurement of induration after 48-72 hours.
Eligibility Criteria
Adult patients undergoing regular hemodialysis at Sohag University Hospital. The study will include patients aged 18 years and older who are clinically stable and able to undergo tuberculin skin testing
You may qualify if:
- Age ≥ 18 years Patients on regular hemodialysis Able and willing to provide informed consent
You may not qualify if:
- active TB patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fatma A Ibrahim, MSc
Faculty of Medicine, Sohag University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Fatma Ahmed Ibrahim
Study Record Dates
First Submitted
September 30, 2025
First Posted
October 7, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 20, 2027
Last Updated
October 7, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared. Only aggregated results will be presented in the thesis and any related publications.